The beauty world is abuzz with controversy following Neutrogena’s response to allegations regarding their treatment of former brand ambassador Hayden Panettiere. The late actress, known for her roles in Nashville and Heroes passed away on August 16, 2026, at the age of 36, leaving behind a legacy that includes her candid discussions about postpartum depression (PPD).
As tributes poured in for Panettiere, so did criticism aimed at Neutrogena, the skincare brand she represented for a decade. The backlash stems from Panettiere’s revelations about the company’s alleged reaction to her public discussions about PPD, sparking a debate about corporate responsibility and mental health advocacy.
Neutrogena’s response to the growing controversy
In the wake of Panettiere’s passing, Neutrogena took to Social Media to address the mounting criticism. The company acknowledged that they had made Panettiere feel unsupported during a very difficult time a statement that came after fans resurfaced her podcast interview and memoir excerpts discussing the brand’s alleged reaction to her PPD disclosures.
The beauty giant expressed their deepest condolences to Panettiere’s family and loved ones, emphasizing that her courage in sharing her challenges helped inspire important conversations and awareness about postpartum mental health. Neutrogena also pledged to make a significant investment in a community health partner to support women’s mental health, including care for PPD.
The timeline of events leading to the backlash
Panettiere first opened up about her struggles with PPD in a 2015 interview, discussing how the condition affected her after the birth of her daughter, Kaya Evdokia Klitschko, in 2014. She described feeling desperate, inadequate, and out of control emotions that she later channeled into her role in Nashville.
In her memoir, This Is Me: A Reckoning published in May 2026, Panettiere detailed how Neutrogena allegedly severed ties with her following her PPD disclosures. She revealed that the company cited a morals clause in her contract as the reason for ending their partnership, a decision that left her feeling betrayed after a decade of collaboration.
The impact of Panettiere’s advocacy
Panettiere’s candid discussions about PPD brought much-needed attention to the condition, which affects 1 in 7 women according to the Cleveland Clinic. Her bravery in sharing her story helped to destigmatize mental health struggles, particularly those related to motherhood. However, the alleged reaction from Neutrogena has raised questions about corporate support for mental health advocacy.
The backlash against Neutrogena has been swift and severe, with fans calling for a boycott of the brand. The controversy has also sparked conversations about the responsibilities of corporations when it comes to supporting the mental health of their partners and employees.
The broader implications for mental health advocacy
The controversy surrounding Neutrogena and Panettiere highlights the ongoing challenges faced by individuals advocating for mental health awareness. While progress has been made in recent years, there is still a long way to go in terms of corporate support and societal understanding of mental health conditions.
Panettiere’s legacy serves as a reminder of the importance of open conversations about mental health, as well as the need for corporations to stand behind their partners in times of vulnerability. As the beauty industry continues to evolve, it is crucial that companies prioritize the well-being of the individuals they represent and the causes they support.
The full extent of Neutrogena’s investment in women’s mental health remains to be seen, but the company’s response to the backlash suggests a willingness to engage with the issue and make meaningful changes. As the conversation around mental health continues to grow, it is essential that corporations like Neutrogena lead by example and demonstrate their commitment to supporting those who advocate for these important causes.
